Key result
Exercise echocardiography distinguishes grey-zone athletes from DCM patients by revealing LVEF increases in ~96%.
Why the study?
Distinguishing early dilated cardiomyopathy from physiological left ventricular dilatation with left ventricular ejection fraction <55% in athletes (grey zone) is challenging.
Does a cascade of investigations, including exercise stress echocardiography, differentiate between physiological LV dilatation in athletes and early dilated cardiomyopathy?
Cohort (n=84)
No
Does a cascade of investigations, including exercise stress echocardiography, differentiate between physiological LV dilatation in athletes and early dilated cardiomyopathy?
Exercise stress echocardiography, specifically the inability to increase LVEF >11% or achieve a peak LVEF >63%, provides the greatest discriminatory value in differentiating physiological LV dilatation in athletes from early dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May aid differentiation of grey-zone LV dilatation on exercise echo; leaves open prospective validation before practice change.
Objective Distinguishing early dilated cardiomyopathy (DCM) from physiological left ventricular (LV) dilatation with LV ejection fraction <55% in athletes (grey zone) is challenging. We evaluated the role of a cascade of investigations to differentiate these two entities. Methods Thirty-five asymptomatic active males with DCM, 25 male athletes in the ‘grey zone’ and 24 male athletes with normal LV ejection fraction underwent N-terminal pro-brain natriuretic peptide (NT-proBNP) measurement, ECG and exercise echocardiography. Grey-zone athletes and patients with DCM underwent cardiovascular magnetic resonance (CMR) and Holter monitoring. Results Larger LV cavity dimensions and lower LV ejection fraction were the only differences between grey-zone and control athletes. None of the grey-zone athletes had abnormal NT-proBNP, increased ectopic burden/complex arrhythmias or pathological late gadolinium enhancement on CMR. These features were also absent in 71%, 71% and 50% of patients with DCM, respectively. 95% of grey-zone athletes and 60% of patients with DCM had normal ECG. During exercise echocardiography, 96% grey-zone athletes increased LV ejection fraction by >11% from baseline to peak exercise compared with 23% of patients with DCM (p<0.0001). Peak LV ejection fraction was >63% in 92% grey-zone athletes compared with 17% patients with DCM (p<0.0001). Failure to increase LV ejection fraction >11% from baseline to peak exercise or achieve a peak LV ejection fraction >63% had sensitivity of 77% and 83%, respectively, and specificity of 96% and 92%, respectively, for predicting DCM. Conclusion Comprehensive assessment using a cascade of routine investigations revealed that exercise stress echocardiography has the greatest discriminatory value in differentiating between grey-zone athletes and asymptomatic patients with DCM. Our findings require validation in larger studies.
No takes yet. Share an insight, caveat, or question.
Millar et al. (2020) conducted a cohort in Dilated cardiomyopathy and athlete’s heart differentiation (n=84). Exercise echocardiography vs. Control athletes was evaluated on Change in left ventricular ejection fraction (LVEF) from baseline to peak exercise (null, 95% CI null, p=<0.0001). Exercise echocardiography showed that 96% of grey-zone athletes increased LVEF by >11% from baseline to peak exercise compared to only 23% of DCM patients.
Synapse has enriched 10 related papers. Consider them for comparative context: